CRN’s annual Tech Elite 250 recognizes solution providers in the U.S. and Canada that have achieved top-tier status within partner programs at some of the leading IT vendors. This year’s list ...

Roche’s Genentech unit bought Jecure Therapeutics and its portfolio of NLRP3 drugs in 2018, focusing on peripheral drugs for NASH, liver fibrosis, gout, inflammatory bowel disease, and ...

Non-alcoholic fatty liver disease (NAFLD) represents the most common liver disease worldwide affecting approximatively 20–30% ...

NASH diagnostics consists of CK-18 total, CK-18 cleaved, adiponectin and resistin. NASH diagnostic panel consists of diabetes, gender, BMI, triglyceride and CK-18 total, CK-18 cleaved levels.

Non-alcoholic steatohepatitis (NASH) is a condition characterized by accumulation of fat, inflammation and injury in liver cells in people who consume little or no alcohol. It is the progressive ...

Changes in how the new Trump administration approaches spending is adding a new level of uncertainty for Accenture, Chair and CEO Julie Sweet told investors.

Producer, marketer, and exporter of a range of Met coals and owns portfolio of operating mines and development projects in Queensland in Australia, and in Virginia, West Virginia, and Pennsylvania ...

Background Intestinal fibrosis resulting in stricture formation and obstruction in Crohn’s disease (CD) and increased wall stiffness leading to symptoms in ulcerative colitis (UC) is among the largest ...